Morgan Stanley’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$478K Sell
34,257
-631
-2% -$8.85K ﹤0.01% 5509
2025
Q4
$502K Buy
34,888
+392
+1% +$5.89K ﹤0.01% 5512
2025
Q3
$549K Buy
34,496
+20,801
+152% +$343K ﹤0.01% 5463
2025
Q2
$242K Sell
13,695
-647,819
-98% -$12.6M ﹤0.01% 5778
2025
Q1
$13.8M Buy
661,514
+8,001
+1% +$152K ﹤0.01% 3054
2024
Q4
$12.1M Sell
653,513
-372
-0.1% -$7.16K ﹤0.01% 3252
2024
Q3
$12.8M Buy
653,885
+46
+0% +$915 ﹤0.01% 3233
2024
Q2
$12.8M Buy
653,839
+648,030
+11,156% +$12.3M ﹤0.01% 3124
2024
Q1
$105K Buy
5,809
+4,253
+273% +$77.2K ﹤0.01% 5976
2023
Q4
$26.4K Buy
+1,556
New +$30.9K ﹤0.01% 6564
2023
Q1
Sell
-15
Closed -$318 7721
2022
Q4
$318 Buy
+15
New +$311 ﹤0.01% 7599
2016
Q2
Sell
-1,000
Closed -$22K 6516
2016
Q1
$22K Buy
+1,000
New +$22.4K ﹤0.01% 5888

Other funds holding BTAL